Dr Lalchandani Labs Limited

₹7.00As of Sun 8 Nov 2026, 12:00 UTC
BSE:541299Healthcare
Country India
PE (Fwd) •••
TSR 8Y CAGR (12.42%)
Div yield —
ROE 0.53%
Medical Laboratories
Beta (5Y) (0.12)
PE TTM 100.0
TSR TTM (59.84%)
Mkt cap ₹60.46M
ROIC (2.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹7.29
4.15%
(87.19%)
Hold 8|12|1|2|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.08
0.09
0.09
0.09
1.06%
1.54%
5.98%
17.33%
Revenue₹M
2.740
2.675
2.646
2.710
1.65%
(0.60%)
(3.11%)
(2.83%)
Peers (US$0.608M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.954
0.335
0.318
EBIT/Intx
0.704
0.044
0.054
Own earn%
66.60
(29.19)
(26.57)
Sh yield%
13.06
5.63
7.75
Owners
Insiders/Inst%
14.76
88.32
Short interest%
4.27
SBC / revenue%
5.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
5–14
$1 testx
0.1
Incr. ROIC%
0